Fortress Biotech, Inc. (FBIO)
2.93
-0.01
(-0.34%)
USD |
NASDAQ |
Dec 12, 09:55
Fortress Biotech Research and Development Expense (Quarterly): 0.208M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Journey Medical Corp. | 0.287M |
| Ultragenyx Pharmaceutical, Inc. | 207.61M |
| Axsome Therapeutics, Inc. | 40.04M |
| Apellis Pharmaceuticals, Inc. | 68.19M |
| Absci Corp. | 19.25M |